Inhibition of Feline (FIPV) and Human (SARS) Coronavirus by Semisynthetic Derivatives of Glycopeptide Antibiotics

Overview

Journal Antiviral Res

Publisher Elsevier

Date 2006 May 6

PMID 16675038

Citations 35

Authors

Jan Balzarini

Els Keyaerts

Leen Vijgen

Herman Egberink

Erik De Clercq

Marc Van Ranst

Svetlana S Printsevskaya

Eugenia N Olsufyeva

Svetlana E Solovieva

Maria N Preobrazhenskaya

Affiliations

Soon will be listed here.

Abstract

Various semisynthetic derivatives of glycopeptide antibiotics including vancomycin, eremomycin, teicoplanin, ristocetin A and DA-40926 have been evaluated for their inhibitory activity against feline infectious peritonitis virus (FIPV) and human (SARS-CoV, Frankfurt-1 strain) coronavirus in cell culture in comparison with their activity against human immunodeficiency virus (HIV). Several glycopeptide derivatives modified with hydrophobic substituents showed selective antiviral activity. For the most active compounds, the 50% effective concentrations (EC(50)) were in the lower micromolar range. In general, removal of the carbohydrate parts of the molecules did not affect the antiviral activity of the compounds. Some compounds showed inhibitory activity against both, whereas other compounds proved inhibitory to either, FIPV or SARS-CoV. There was no close correlation between the EC(50) values of the glycopeptide derivatives for FIPV or SARS-CoV.

Citing Articles

Advancements in the development of antivirals against SARS-Coronavirus.

Kumar M, Baig M, Bhardwaj K Front Cell Infect Microbiol. 2025; 15:1520811.

PMID: 39917633 PMC: 11798951. DOI: 10.3389/fcimb.2025.1520811.

Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines.

Solyev P, Isakova E, Olsufyeva E Antibiotics (Basel). 2023; 12(5).

PMID: 37237799 PMC: 10215198. DOI: 10.3390/antibiotics12050894.

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.

Bereczki I, Papp H, Kuczmog A, Madai M, Nagy V, Agocs A Pharmaceuticals (Basel). 2021; 14(11).

PMID: 34832893 PMC: 8619593. DOI: 10.3390/ph14111111.

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.

Geraghty R, Aliota M, Bonnac L Viruses. 2021; 13(4).

PMID: 33924302 PMC: 8069527. DOI: 10.3390/v13040667.

Potential therapeutic and pharmacological strategies for SARS-CoV2.

Ghareeb D, Saleh S, Nofal M, Kaddah M, Hassan S, Seif I J Pharm Investig. 2021; 51(3):281-296.

PMID: 33688448 PMC: 7933375. DOI: 10.1007/s40005-021-00520-4.

References

Malabarba A, Trani A, Strazzolini P, Cietto G, Ferrari P, Tarzia G . Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships. J Med Chem. 1989; 32(11):2450-60. DOI: 10.1021/jm00131a007. View

Malabarba A, Ferrari P, GALLO G, Kettenring J, CAVALLERI B . Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR characteristics of the aglycone of teicoplanin. J Antibiot (Tokyo). 1986; 39(10):1430-42. DOI: 10.7164/antibiotics.39.1430. View

Pavlov A, Lazhko E, Preobrazhenskaya M . A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity. J Antibiot (Tokyo). 1997; 50(6):509-13. DOI: 10.7164/antibiotics.50.509. View

Pavlov A, Berdnikova T, Olsufyeva E, Lazhko E, Malkova I, Preobrazhenskaya M . Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal. J Antibiot (Tokyo). 1993; 46(11):1731-9. DOI: 10.7164/antibiotics.46.1731. View

Trani A, Ferrari P, PALLANZA R, Ciabatti R . Thioureas and isothiouronium salts of the aglycone of teicoplanin. I. Synthesis and biological activity. J Antibiot (Tokyo). 1989; 42(8):1268-75. DOI: 10.7164/antibiotics.42.1268. View

Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

Malabarba A, Trani A, Kettenring J, Gerli E, PALLANZA R, Berti M . N15-alkyl and N15,N15-dialkyl derivatives of teicoplanin antibiotics. J Antibiot (Tokyo). 1990; 43(9):1107-21. DOI: 10.7164/antibiotics.43.1107. View

Malabarba A, Ciabatti R, Kettenring J, Scotti R, Candiani G, PALLANZA R . Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines. J Med Chem. 1992; 35(22):4054-60. DOI: 10.1021/jm00100a010. View

Miroshnikova O, Berdnikova T, Olsufyeva E, Pavlov A, Reznikova M, Preobrazhenskaya M . A modification of the N-terminal amino acid in the eremomycin aglycone. J Antibiot (Tokyo). 1996; 49(11):1157-61. DOI: 10.7164/antibiotics.49.1157. View

10.

Pavlov A, Berdnikova T, Olsufyeva E, Miroshnikova O, Filipposyanz S, Preobrazhenskaya M . Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity. J Antibiot (Tokyo). 1996; 49(2):194-8. DOI: 10.7164/antibiotics.49.194. View

11.

Printsevskaya S, Pavlov A, Olsufyeva E, Mirchink E, Preobrazhenskaya M . Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. J Med Chem. 2003; 46(7):1204-9. DOI: 10.1021/jm020320o. View

12.

Miroshnikova O, Printsevskaya S, Olsufyeva E, Pavlov A, Nilius A, Preobrazhenskaya M . Structure-activity relationships in the series of eremomycin carboxamides. J Antibiot (Tokyo). 2000; 53(3):286-93. DOI: 10.7164/antibiotics.53.286. View

13.

Song H, Tu C, Zhang G, Wang S, Zheng K, Lei L . Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A. 2005; 102(7):2430-5. PMC: 548959. DOI: 10.1073/pnas.0409608102. View

14.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

15.

WALSH C . Vancomycin resistance: decoding the molecular logic. Science. 1993; 261(5119):308-9. DOI: 10.1126/science.8392747. View

16.

Printsevskaya S, Pavlov A, Olsufyeva E, Mirchink E, Isakova E, Reznikova M . Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria. J Med Chem. 2002; 45(6):1340-7. DOI: 10.1021/jm010460i. View

17.

Holmes K . SARS-associated coronavirus. N Engl J Med. 2003; 348(20):1948-51. DOI: 10.1056/NEJMp030078. View

18.

Maffioli S, Ciabatti R, Romano G, Marzorati E, Preobrazhenskaya M, Pavlov A . Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides. Bioorg Med Chem Lett. 2005; 15(16):3801-5. DOI: 10.1016/j.bmcl.2005.05.076. View

19.

Hermann R, Ripamonti F, Romano G, Restelli E, Ferrari P, Goldstein B . Synthesis and antibacterial activity of derivatives of the glycopeptide antibiotic A-40926 and its aglycone. J Antibiot (Tokyo). 1996; 49(12):1236-48. DOI: 10.7164/antibiotics.49.1236. View

20.

Guan Y, Zheng B, He Y, Liu X, Zhuang Z, Cheung C . Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003; 302(5643):276-8. DOI: 10.1126/science.1087139. View